DxGen Corp. of Gyeonggi-do at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

DxGen Corp.

Rm 303-1, Hanlim Human Tower, 172 LS-ro, 15807 Gyeonggi-do
Korea, Republic
Telephone +82 31 4278450
Fax +82 50 80908450

This company is co-exhibitor of
Zeta Corporation

Hall map

MEDICA 2018 hall map (Hall 3): stand K20

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 02  Laboratory Technology
  • 02.01  Analyser systems / equipment

Our products

Product category: Analyser systems / equipment

Beyond HbA1c, Glycated Albumin goes to Point-Of-Care Testing (POCT).

  • DxGen is Point-Of-Care (POC) diagnostics company devoted to developing multi-marker for people with diabetes and tuberculosis. Epithod®616 and Epithod®AutoDx (fully automated) are the 1st POC analyzers for testing HbA1c and Glycated Albumin. HbA1c and Glycated Albumin tests together provide more precise assessment to cover the entire stage of diabetes care from initial assessment, treatment efficacy, and long-term monitoring. 
  • Products are the most cost-effective system for small-and mid-sized laboratory, clinic and doctor's office. Lab-quality accuracy and immediate results are for quality patient care. 
  • Furthermore, the next parameters are planning to expand as Tuberculosis (TB), CRP/hs-CRP, Hemoglobin, Microalbumin and so on.

More Less

Company news




Feb 7, 2019

MEDICA 2018, Düsseldorf, Germany

The MEDICA was successfully held on 12- 15 November 2018.
It was very pleasure to meet all visitors and sincerely appreciate many interests and supports to our products
–Point-Of-Care Testing (HbA1c, Glycated Albumin, Tuberculosis Ag, CRP/hs-CRP, Hemoglobin and μ-Albumin).
Hope you can be a part of our endeavor and have a chance to establish a successful business partnership.
If you need further assistance, please contact us to sales@dxgenco.com.

More Less

About us

Company details

DxGen is global Point-Of-Care(POC) diagnostics company. Our goal is to help make clinical decisions in the care and treatment of patients at the time and place. We are committed to applying leading-edge technology for high-quality products. We endeavor to be a global leader and deliver technical innovation continuously. 

More Less